Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details
Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

NCT06800963

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Arizona Clinical Trials Chandler, Arizona, United States
  • Golden State Urology Sacramento, California, United States
  • Emory University Atlanta, Georgia, United States
  • Michigan Institute of Urology & Solaris Health Troy, Michigan, United States
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Humanitas Gavezzeni-Bergamo Bergamo, Italy
  • Ospedale Sant'Orsola - Malpighi Bologna, Italy
  • Policlinico Ospedali Riuniti - Foggia Foggia, Italy
  • Istituto Oncologico Veneto IRCCS Padova, Italy
View Trial Details

Related conditions